Patel, Riyaz S. http://orcid.org/0000-0003-4603-2393
Pasea, Laura
Soran, Handrean
Downie, Paul
Jones, Richard
Hingorani, Aroon D.
Neely, Dermot
Denaxas, Spiros
Hemingway, Harry
Funding for this research was provided by:
British Heart Foundation (FS/14/76/30933)
Akcea Therapeutics
Article History
Received: 4 February 2022
Accepted: 21 April 2022
First Online: 9 June 2022
Declarations
:
: This study is based in part on data from the Clinical Practice Research Datalink obtained under licence from the UK Medicines and Healthcare products Regulatory Agency. The data is provided by patients and collected by the NHS as part of their care and support. The interpretation and conclusions contained in this study are those of the author/s alone. The study was approved by the MHRA (UK) Independent Scientific Advisory Committee 17_033, under Sect. 251 (NHS Social Care Act 2006).
: Not applicable.
: Analysis was funded through a research grant provided by AkceaTherepeutics. RJ is an employee of AkceaTherepeutics and provided intellectual input into the study design and final review of the manuscript, but was not involved in analysis or writing of the paper.
: RSP has received speaker fees and honoraria from Amgen, Sanofi and Bayer and research grant funding from Regeneron, for cholesterol management; no other relationships or activities that could appear to have influenced the submitted work. HS has received research grants and honoraria from AMGEN, AMRYT, MSD, AKEA and Alexion.